In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA

British Journal of Pharmacology

Volumn 134, Issue 7, 2001, Pages 1455-1460

  Cannon, Dara M ^a   Keenan, Alan K ^a   Guiry, Patrick J ^a   Buon, Christophe ^a   Baird, Alan W ^a   McBean, Gethin J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

5 HT; 5 HT induced aortic contraction; MDMA; Synaptosomal re uptake

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTERY CONSTRICTION; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; SPECIES DIFFERENCE; STRAIN DIFFERENCE; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

EID: 0035214357     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704402     Document Type: Article

References (34)

1. Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylenedioxymethamphetamine (Ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase
2. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice
3. Centrally acting N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)
4. Cardiovascular antonomic dysregulation in users of MDMA ('Ecstasy')
5. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion
6. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA (Ecstasy) and p-chloroamphetamine but not following fenfluramine
7. Biochemical and histological evidence that MDMA is toxic to neurons in the rat brain
8. 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA
9. A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction; homogeneity and morphology of subcellular fractions
10. 3,4-methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally ata concentration occurring following a peripherally injected neurotoxic dose
11. Sympathomimetic actions of methylenedioxymethamphetamine in rat and rabbit isolated cardiovascular tissue
12. Mechanisms of extraneuronal serotonin uptake in the rat aorta
13. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat
14. 1A receptor agonist (+/-)-8-hydroxy-(di-n-proplyamino)tetralin
15. MDMA. The dark side of ecstasy
16. 5-Hydroxytryptamine blockers attenuate the 5-Hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents
17. 2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens
18. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
19. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans
20. 2-adrenoceptors in the anaesthetised rat
21. 3H]-serotonin
22. A comparison of the in vitro effects of (+)-4-methylthioamphetamine and (+)-MDMA on 5-HT re-uptake in the brain and on vascular responses to 5-HT
23. Pathology of deaths associated with 'ecstasy' and 'eve' misuse
24. 3H]paroxetine binding in the frontal cortex and blood platelets of rats
25. 3H]-serotonin from rat brain synaptosomes
26. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat
27. Diminished corticotropin and enhanced prolactin responses to 8-hydroxy-2-(di-n-propylamino) tetralin in methylenedioxymethamphetamine pretreated rats
28. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: Preliminary observations
29. The molecular mechanism of 'ecstasy' [3,4-methylenedioxymethamphetamine(MDMA)]: Serotonin transporters are targets for MDMA-induced serotonin release
30. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partiaI recovery over a 52-week period. Part I: SynaptosomaI uptake and tissue concentrations
31. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine
32. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain
33. 'Ecstasy' and sudden cardiac death
34. Psychological and cardiovascular effects and short-term sequelae of MDMA ('Ecstasy') in MDMA-naïve healthy volunteers